CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-19 | KOCH KEVIN Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-19 | Hughes Thomas E. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-19 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-19 | Bowden Christopher Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-04-03 | Hughes Thomas E. Director | Grant or award · Stock Option (right to buy) | +10,106 | 10,106 | ||
| 2019-02-06 | RUBIN PAUL D EVP, Research & Development | Grant or award · Stock Option (right to buy) | +87,000 | 87,000 | ||
| 2019-02-06 | Levy Adam Scott Chief Business Officer | Grant or award · Stock Option (right to buy) | +74,000 | 74,000 | ||
| 2019-02-06 | Leverone Jason A. CFO, Treasurer & Secretary | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-02-06 | Marshall William Stuart President & CEO | Grant or award · Stock Option (right to buy) | +232,000 | 232,000 | ||
| 2018-10-11 | Hughes Thomas E. Director | Purchase | +10,000 | $4.77 | $48K | 12,827 |
| 2018-08-07 | Leverone Jason A. CFO, Treasurer & Secretary | Option exercise | +29,530 | $0.57 | $17K | 30,737 |
| 2018-08-07 | Leverone Jason A. CFO, Treasurer & Secretary | Option exercise · Stock Option (right to buy) | −29,530 | 0 | ||
| 2018-06-27 | TURNER JOSEPH L Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-06-27 | Morris Arlene Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-06-27 | KOCH KEVIN Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-06-27 | Hughes Thomas E. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-06-27 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-06-27 | Bowden Christopher Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-06-27 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-02-13 | Marshall William Stuart President & CEO | Option exercise | +115,818 | $0.57 | $66K | 265,646 |
Page 12 of 16 · 309 trades